Brand Name(s): Bactroban, Centany
CAS nº: 12650-69-0
(myoo peer’ oh sin)
About Mupirocin
This new site is dedicated exclusively to mupirocin.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about mupirocin on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total mupirocin experience!
Why is this medication prescribed?
Mupirocin, an antibiotic, is used to treat impetigo as well as other skin infections caused by bacteria. It is not effective, however, against fungal or viral infections.
Unlike other antibiotics which act on either bacterial DNA or the cellular walls of bacteria, mupirocin blocks the activity of an enzyme called isoleucyl-tRNA synthetase within the bacteria. This enzyme is necessary in order for the bacteria to make proteins. Without the ability to make proteins, the bacteria dies.
Latest News
Biofilms: Recent Study Supports Elimination of Biofilm Colonies; Sinus Patients may Benefit
Aerosol Science Laboratories (ASL Pharmacy) announces today a new formula for topical sinus use...
[more]GSK Receives Approvable Letter for Topical Antibiotic, Altabax™ (retapamulin ointment), 1%
GlaxoSmithKline (GSK) announced today that the U.S. Food and Drug Administration has issued an...
[more]Replidyne Commences Clinical Trials For REP8839
Replidyne, Inc. (Nasdaq: RDYN) announced today the initiation of Phase I clinical testing of its...
[more]Replidyne enters clinical testing
Replidyne Inc. has initiated Phase I clinical testing of its topical anti-infective drug candidate...
[more]New Topical Antibiotic May Inhibit Skin Infections in Humans
Researchers from Colorado have identified a new topical antibiotic that may inhibit skin infections...
[more]